Ardsley Advisory Partners’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-510,000
| Closed | -$10.2M | – | 165 |
|
|
2018
Q3 | $10.2M | Buy |
510,000
+250,000
| +96% | +$5M | 1.38% | 18 |
|
|
2018
Q2 | $6.72M | Buy |
260,000
+40,000
| +18% | +$1.03M | 1.01% | 33 |
|
|
2018
Q1 | $5.25M | Buy |
220,000
+65,000
| +42% | +$1.55M | 0.79% | 40 |
|
|
2017
Q4 | $5.25M | Buy |
+155,000
| New | +$5.25M | 0.64% | 32 |
|
|
2017
Q3 | – | Sell |
-15,000
| Closed | -$262K | – | 159 |
|
|
2017
Q2 | $262K | Hold |
15,000
| – | – | 0.04% | 102 |
|
|
2017
Q1 | $263K | Hold |
15,000
| – | – | 0.04% | 100 |
|
|
2016
Q4 | $254K | Hold |
15,000
| – | – | 0.04% | 97 |
|
|
2016
Q3 | $246K | Buy |
+15,000
| New | +$246K | 0.04% | 114 |
|